JESSICA CHUN: Open Payments
NPI 1528466737 · FALLS CHURCH, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,263 in 40 payments from 15 companies in 2025. Trend: 2023 $625 · 2024 $763 · 2025 $1,263
Food & beverage: $1,263
| Company | Payments | Amount |
|---|---|---|
| United Therapeutics Corporation | 11 | $499 |
| Actelion Pharmaceuticals US, Inc. | 5 | $139 |
| Merck Sharp & Dohme LLC | 1 | $118 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 6 | $112 |
| Takeda Pharmaceuticals U.S.A., Inc. | 3 | $80 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $77 |
| Melinta Therapeutics, LLC | 3 | $53 |
| Astellas Pharma US Inc | 1 | $32 |
| ANI Pharmaceuticals, Inc. | 1 | $31 |
| ABBVIE INC. | 1 | $26 |
Products named: Remodulin, Tyvaso, Orenitram, UPTRAVI, LIVTENCITY, Adempas, OFEV, Rezzayo.
Industry payments across VA — which companies pay providers there.
